Works by Lind, Marcus

Results: 78
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Glycaemic control and sepsis risk in adults with type 1 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1942, doi. 10.1111/dom.15060
    By:
    • Balintescu, Anca;
    • Lind, Marcus;
    • Andersson Franko, Mikael;
    • Oldner, Anders;
    • Cronhjort, Maria;
    • Eliasson, Björn;
    • Svensen, Christer;
    • Mårtensson, Johan
    Publication type:
    Article
    10

    The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5).

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 619, doi. 10.1111/dom.14257
    By:
    • Ólafsdóttir, Arndís F.;
    • Bolinder, Jan;
    • Heise, Tim;
    • Polonsky, William;
    • Ekelund, Magnus;
    • Wijkman, Magnus;
    • Pivodic, Aldina;
    • Ahlén, Elsa;
    • Schwarcz, Erik;
    • Nyström, Thomas;
    • Hellman, Jarl;
    • Hirsch, Irl B.;
    • Lind, Marcus
    Publication type:
    Article
    11

    Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 549, doi. 10.1111/dom.14248
    By:
    • Phillip, Moshe;
    • Mathieu, Chantal;
    • Lind, Marcus;
    • Araki, Eiichi;
    • Bartolo, Paolo;
    • Bergenstal, Richard;
    • Heller, Simon;
    • Hansen, Lars;
    • Scheerer, Markus Florian;
    • Thoren, Fredrik;
    • Arya, Niki;
    • Xu, John;
    • Iqbal, Nayyar;
    • Dandona, Paresh
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    Discordance between mean glucose and time in range in relation to HbA<sub>1c</sub> in individuals with type 1 diabetes: results from the GOLD and SILVER trials.

    Published in:
    Diabetologia, 2024, v. 67, n. 8, p. 1517, doi. 10.1007/s00125-024-06151-2
    By:
    • Sterner Isaksson, Sofia;
    • Imberg, Henrik;
    • Hirsch, Irl B.;
    • Schwarcz, Erik;
    • Hellman, Jarl;
    • Wijkman, Magnus;
    • Bolinder, Jan;
    • Nyström, Thomas;
    • Holmer, Helene;
    • Hallström, Sara;
    • Ólafsdóttir, Arndís F.;
    • Pekkari, Sofia;
    • Polonsky, William;
    • Lind, Marcus
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes.

    Published in:
    Journal of Diabetes Science & Technology, 2025, v. 19, n. 1, p. 217, doi. 10.1177/19322968241292041
    By:
    • Rhee, Connie M.;
    • Gianchandani, Roma Y.;
    • Kerr, David;
    • Philis-Tsimikas, Athena;
    • Kovesdy, Csaba P.;
    • Stanton, Robert C.;
    • Drincic, Andjela T.;
    • Galindo, Rodolfo J.;
    • Kalantar-Zadeh, Kamyar;
    • Neumiller, Joshua J.;
    • de Boer, Ian H.;
    • Lind, Marcus;
    • Kim, Sun H.;
    • Ayers, Alessandra T.;
    • Ho, Cindy N.;
    • Aaron, Rachel E.;
    • Tian, Tiffany;
    • Klonoff, David C.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33

    Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 9, p. 2644, doi. 10.1210/clinem/dgac343
    By:
    • Nowak, Christoph;
    • Lind, Marcus;
    • Sumnik, Zdenek;
    • Pelikanova, Terezie;
    • Nattero-Chavez, Lía;
    • Lundberg, Elena;
    • Rica, Itxaso;
    • Martínez-Brocca, Maria A.;
    • Ruiz de Adana, MariSol;
    • Wahlberg, Jeanette;
    • Hanas, Ragnar;
    • Hernandez, Cristina;
    • Clemente-León, Maria;
    • Gómez-Gila, Ana;
    • Ferrer Lozano, Marta;
    • Sas, Theo;
    • Pruhova, Stepanka;
    • Dietrich, Fabricia;
    • Puente-Marin, Sara;
    • Hannelius, Ulf
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 2035, doi. 10.3390/jcm12052035
    By:
    • Gabriel, Rafael;
    • Boukichou-Abdelkader, Nisa;
    • Gilis-Januszewska, Aleksandra;
    • Makrilakis, Konstantinos;
    • Gómez-Huelgas, Ricardo;
    • Kamenov, Zdravko;
    • Paulweber, Bernhard;
    • Satman, Ilhan;
    • Djordjevic, Predrag;
    • Alkandari, Abdullah;
    • Mitrakou, Asimina;
    • Lalic, Nebojsa;
    • Egido, Jesús;
    • Más-Fontao, Sebastián;
    • Calvet, Jean Henri;
    • Pastor, José Carlos;
    • Lindström, Jaana;
    • Lind, Marcus;
    • Acosta, Tania;
    • Silva, Luis
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial.

    Published in:
    2021
    By:
    • Ludvigsson, Johnny;
    • Sumnik, Zdenek;
    • Pelikanova, Terezie;
    • Nattero Chavez, Lia;
    • Lundberg, Elena;
    • Rica, Itxaso;
    • Martínez-Brocca, Maria A.;
    • Ruiz de Adana, Marisol;
    • Wahlberg, Jeanette;
    • Katsarou, Anastasia;
    • Hanas, Ragnar;
    • Hernandez, Cristina;
    • Clemente León, Maria;
    • Gómez-Gila, Ana;
    • Lind, Marcus;
    • Lozano, Marta Ferrer;
    • Sas, Theo;
    • Samuelsson, Ulf;
    • Pruhova, Stepanka;
    • Dietrich, Fabricia
    Publication type:
    journal article